# By 2030, the market for acne medications will expand at a 3.1% CAGR.

**The global market for acne medications was estimated to be worth USD 10.92 billion in 2022 and is projected to reach USD 14.26 billion by 2030, with a CAGR of 3.1% from 2023 to 2030. This growth is attributed to rising consumer awareness of skincare products as well as the adoption of organic and healthy diets.**

The global market for acne medications is growing as people become more aware of choices for treating acne to improve facial attractiveness.

The usage of acne drugs can cause adverse effects like skin irritability, dry skin, and erythema, which limit market expansion.

Moreover, the market for acne medications is anticipated to experience strong growth due to the development of photo pneumatic technologies for the treatment of acne and the usage of skin rejuvenation techniques including dermabrasion, microdermabrasion, and mesotherapy.

**Request for a sample here: https://www.nextmsc.com/acne-medication-market/request-sample**

The market for acne medications is segmented by therapeutic class into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. The market is split between topical and oral drugs based on formulation. The market is further segmented by type into over-the-counter and prescription medications. There are two types of acne: inflammatory acne and non-inflammatory acne. It is divided into retail outlets, e-commerce, and pharmacies and pharmacy stores based on the distribution route. The market is examined in terms of its impact on North America, Europe, Asia Pacific, and the rest of the world.

**Enquire before buying: https://www.nextmsc.com/acne-medication-market/inquire-before-buying**

Due to unhealthy lifestyles, particularly the food of the urban population, which contributes to the incidence of acne in this region, North America has been the top consumer of acne medications. Almost 50 million Americans had acne in 2021, according to the American Academy of Dermatology (AAD).

Also, the presence of major acne pharmaceutical players like Bausch Health Companies Inc., Mylan N.V., Pfizer Inc., and Johnson & Johnson further stimulates the growth of the market in the area.

Acne is predicted to become more common in Europe, with better access to effective treatment and more medication readily available. Moreover, the availability of experienced dermatologists and an increase in expenditure on cosmetics and aesthetics are anticipated to fuel market expansion.

**Avail customization in reports: https://www.nextmsc.com/services**

Some of the top companies in the production of acne medications are Procter & Gamble, Unilever PLC, Obagi Medical, Avon Products, Inc., Herbalife Nutrition Ltd., Beiersdorf Aktiengesellschaft, Abbvie Inc., Galderma, Estee Lauder Companies Inc., GlaxoSmithKline Plc., Johnson & Johnson, Neutrogena Corporation, Himalaya, Almirall S.A., Bausch Health Companies Inc., Amway Corporation, Abbott

**Buy the report directly: https://www.nextmsc.com/report/acne-medication-market**

**Related Reports:**
**[Professional Acne Medication](https://www.nextmsc.com/report/professional-acne-medication-market)**
**[Ceramide Market](https://www.nextmsc.com/report/ceramide-market)**
**[Spirulina Market](https://www.nextmsc.com/report/spirulina-market)**

**About Us:**
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to delivering high-quality market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing a greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining, and data analytics.

We have been providing services to over 1,000 customers globally, with 90% of the Fortune 500 companies, over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or industry. We provide one of the industry’s best quality syndicate as well as custom research reports, across 10 different industry verticals. We are committed to delivering high quality research solutions in accordance to your business needs. Our industry standard delivery solutions range from pre-consultation to after-sales services to provide an excellent client experience and ensure right strategic decision making for businesses.

**For more insights, please visit, https://www.nextmsc.com**